Coating nanocarriers with hyaluronic acid facilitates intravitreal drug delivery for retinal gene therapy
- Author
- Thomas Martens (UGent) , Katrien Remaut (UGent) , Hendrik Deschout (UGent) , Johan FJ Engbersen, Wim E Hennink, Mies J van Steenbergen, Jo Demeester (UGent) , Stefaan De Smedt (UGent) and Kevin Braeckmans (UGent)
- Organization
- Project
- Keywords
- LIPOSOMES, CANCER, CD44 RECEPTOR, EPITHELIAL-CELLS, COATED NANOPARTICLES, CD44-HYALURONAN INTERACTIONS, CONGENITAL AMAUROSIS, RECEPTOR-MEDIATED UPTAKE, MOLECULAR-WEIGHT HYALURONAN, BIOREDUCIBLE POLY(AMIDO AMINE)S, Molecular weight, Polyplexes, Retinal gene delivery, Hyaluronic acid, Intravitreal
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 1.02 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-5923088
- MLA
- Martens, Thomas et al. “Coating Nanocarriers with Hyaluronic Acid Facilitates Intravitreal Drug Delivery for Retinal Gene Therapy.” JOURNAL OF CONTROLLED RELEASE 202 (2015): 83–92. Print.
- APA
- Martens, T., Remaut, K., Deschout, H., Engbersen, J. F., Hennink, W. E., van Steenbergen, M. J., Demeester, J., et al. (2015). Coating nanocarriers with hyaluronic acid facilitates intravitreal drug delivery for retinal gene therapy. JOURNAL OF CONTROLLED RELEASE, 202, 83–92.
- Chicago author-date
- Martens, Thomas, Katrien Remaut, Hendrik Deschout, Johan FJ Engbersen, Wim E Hennink, Mies J van Steenbergen, Jo Demeester, Stefaan De Smedt, and Kevin Braeckmans. 2015. “Coating Nanocarriers with Hyaluronic Acid Facilitates Intravitreal Drug Delivery for Retinal Gene Therapy.” Journal of Controlled Release 202: 83–92.
- Chicago author-date (all authors)
- Martens, Thomas, Katrien Remaut, Hendrik Deschout, Johan FJ Engbersen, Wim E Hennink, Mies J van Steenbergen, Jo Demeester, Stefaan De Smedt, and Kevin Braeckmans. 2015. “Coating Nanocarriers with Hyaluronic Acid Facilitates Intravitreal Drug Delivery for Retinal Gene Therapy.” Journal of Controlled Release 202: 83–92.
- Vancouver
- 1.Martens T, Remaut K, Deschout H, Engbersen JF, Hennink WE, van Steenbergen MJ, et al. Coating nanocarriers with hyaluronic acid facilitates intravitreal drug delivery for retinal gene therapy. JOURNAL OF CONTROLLED RELEASE. 2015;202:83–92.
- IEEE
- [1]T. Martens et al., “Coating nanocarriers with hyaluronic acid facilitates intravitreal drug delivery for retinal gene therapy,” JOURNAL OF CONTROLLED RELEASE, vol. 202, pp. 83–92, 2015.
@article{5923088,
author = {Martens, Thomas and Remaut, Katrien and Deschout, Hendrik and Engbersen, Johan FJ and Hennink, Wim E and van Steenbergen, Mies J and Demeester, Jo and De Smedt, Stefaan and Braeckmans, Kevin},
issn = {0168-3659},
journal = {JOURNAL OF CONTROLLED RELEASE},
keywords = {LIPOSOMES,CANCER,CD44 RECEPTOR,EPITHELIAL-CELLS,COATED NANOPARTICLES,CD44-HYALURONAN INTERACTIONS,CONGENITAL AMAUROSIS,RECEPTOR-MEDIATED UPTAKE,MOLECULAR-WEIGHT HYALURONAN,BIOREDUCIBLE POLY(AMIDO AMINE)S,Molecular weight,Polyplexes,Retinal gene delivery,Hyaluronic acid,Intravitreal},
language = {eng},
pages = {83--92},
title = {Coating nanocarriers with hyaluronic acid facilitates intravitreal drug delivery for retinal gene therapy},
url = {http://dx.doi.org/10.1016/j.jconrel.2015.01.030},
volume = {202},
year = {2015},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: